- Report
- March 2024
- 183 Pages
Global
From €3253EUR$3,374USD£2,782GBP
€3614EUR$3,749USD£3,091GBP
- Report
- May 2024
- 182 Pages
Global
From €4772EUR$4,950USD£4,081GBP
- Report
- February 2024
- 175 Pages
Global
From €4821EUR$5,000USD£4,123GBP
- Report
- December 2023
- 114 Pages
Global
From €4290EUR$4,450USD£3,669GBP
- Report
- March 2024
- 182 Pages
Global
From €3253EUR$3,374USD£2,782GBP
€3614EUR$3,749USD£3,091GBP
- Report
- May 2024
- 179 Pages
Global
From €4772EUR$4,950USD£4,081GBP
- Report
- February 2024
- 175 Pages
Global
From €4821EUR$5,000USD£4,123GBP
- Report
- March 2024
- 170 Pages
Global
€4816EUR$4,995USD£4,119GBP
- Report
- November 2020
- 141 Pages
Global
From €1326EUR$1,375USD£1,134GBP
€2651EUR$2,750USD£2,267GBP
- Report
- August 2019
- 325 Pages
Global
From €1326EUR$1,375USD£1,134GBP
€2651EUR$2,750USD£2,267GBP
- Report
- January 2019
- 120 Pages
Global
From €1326EUR$1,375USD£1,134GBP
€2651EUR$2,750USD£2,267GBP
- Report
- January 2018
- 197 Days
Global
From €4025EUR$4,175USD£3,442GBP
- Report
- April 2024
- 175 Pages
From €4821EUR$5,000USD£4,123GBP
- Report
- July 2022
- 100 Pages
Global
From €2651EUR$2,750USD£2,267GBP
- Report
- October 2018
- 144 Pages
Global
From €3071EUR$3,185USD£2,626GBP
€4387EUR$4,550USD£3,752GBP
- Report
- June 2020
- 111 Pages
Global
From €4579EUR$4,750USD£3,917GBP
- Webinar
- May 2021
- 6 Hours
Europe
From €574EUR$595USD£491GBP
- Webinar
- January 2018
- 90 Minutes
Europe
- Report
- February 2024
- 93 Pages
Global
From €3500EUR$3,889USD£3,098GBP
- Report
- May 2023
- 110 Pages
Global
From €3500EUR$3,889USD£3,098GBP
The Active Implantable Medical Device (AIMD) market is a subset of the medical device industry that focuses on the development and production of medical devices that are implanted into the body. These devices are designed to monitor, diagnose, and treat a variety of medical conditions. AIMDs are typically powered by batteries and are designed to be implanted for long-term use. Examples of AIMDs include pacemakers, implantable cardioverter defibrillators, neurostimulators, and drug delivery systems.
AIMDs are regulated by the Food and Drug Administration (FDA) and must meet stringent safety and efficacy standards. The market is highly competitive, with a number of large companies competing for market share.
Some of the major players in the AIMD market include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and Biotronik. Show Less Read more